Cubist Systematic Strategies, LLC Vericel Corp Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$32.52 - $52.33 $1.87 Million - $3.01 Million	57,433 Added 1406.98%	61,515 $3.2 Million
Q4 2023 Feb 14, 2024	SELL	$30.85 - $37.09 $1.52 Million - $1.82 Million	-49,126 Reduced 92.33%	4,082 $145,000
Q3 2023 Nov 14, 2023	SELL	$31.69 - $39.25 $829,961 - $1.03 Million	-26,190 Reduced 32.99%	53,208 $1.78 Million
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $1.48 Million - $1.96 Million	51,173 Added 181.3%	79,398 $2.98 Million
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $162,227 - $213,174	6,802 Added 31.75%	28,225 $827,000
Q4 2022 Feb 14, 2023	SELL	$17.65 - $27.37 $146,442 - $227,088	-8,297 Reduced 27.92%	21,423 $564,000
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $174,174 - $250,558	7,700 Added 34.97%	29,720 $690,000
Q2 2022 Aug 15, 2022	SELL	$22.88 - $39.45 $402,253 - $693,570	-17,581 Reduced 44.4%	22,020 $554,000
Q1 2022 May 16, 2022	BUY	$31.69 - $43.29 $846,123 - $1.16 Million	26,700 Added 206.96%	39,601 $1.51 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $165,756 - $247,693	-4,709 Reduced 26.74%	12,901 $507,000
Q3 2021 Nov 15, 2021	SELL	$46.35 - $59.75 $833,326 - $1.07 Million	-17,979 Reduced 50.52%	17,610 $859,000
Q2 2021 Aug 16, 2021	BUY	$47.2 - $67.81 $1.05 Million - $1.52 Million	22,350 Added 168.82%	35,589 $1.87 Million
Q1 2021 May 17, 2021	SELL	$30.93 - $59.48 $501,653 - $964,706	-16,219 Reduced 55.06%	13,239 $735,000
Q4 2020 Feb 16, 2021	BUY	$18.53 - $31.5 $34,929 - $59,377	1,885 Added 6.84%	29,458 $910,000
Q3 2020 Nov 16, 2020	SELL	$14.68 - $19.12 $317,366 - $413,355	-21,619 Reduced 43.95%	27,573 $511,000
Q2 2020 Aug 14, 2020	BUY	$8.5 - $15.82 $2,796 - $5,204	329 Added 0.67%	49,192 $680,000
Q1 2020 May 15, 2020	BUY	$7.25 - $19.22 $210,909 - $559,129	29,091 Added 147.13%	48,863 $448,000
Q4 2019 Feb 14, 2020	BUY	$13.77 - $19.2 $272,260 - $379,622	19,772 New	19,772 $344,000
Q3 2019 Nov 14, 2019	SELL	$14.93 - $19.83 $1,493 - $1,982	-100 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $122,391 - $154,029	-8,154 Reduced 98.79%	100 $2,000
Q1 2019 May 15, 2019	SELL	$16.23 - $20.29 $838,961 - $1.05 Million	-51,692 Reduced 86.23%	8,254 $145,000
Q4 2018 Feb 14, 2019	BUY	$10.77 - $18.44 $538,219 - $921,520	49,974 Added 501.14%	59,946 $1.04 Million
Q3 2018 Nov 14, 2018	SELL	$9.1 - $14.8 $114,641 - $186,450	-12,598 Reduced 55.82%	9,972 $141,000
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $7,929 - $12,059	826 Added 3.8%	22,570 $219,000
Q1 2018 May 15, 2018	BUY	$5.7 - $12.3 $123,940 - $267,451	21,744 New	21,744 $216,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.5M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account